Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Afatinib × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 10 Head & Neck 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Brain Neoplasms 1 Blast Crisis 1 Anemia 1

Interventions

pembrolizumab 16 Magnetic Resonance Spectroscopy 16 Specimen Handling 11 Radiotherapy 11 Docetaxel 11 Surveys and Questionnaires 9 Cyclophosphamide 9 Radiosurgery 8 Gemcitabine 7 Blood Specimen Collection 7 sargramostim 6 Injections 6 Early Intervention, Educational 6 Psychiatric Rehabilitation 5 Paclitaxel 5 Nivolumab 5 Methods 5 Interviews as Topic 5 Educational Status 5 Drug Therapy 5 spartalizumab 4 motexafin gadolinium 4 Trastuzumab 4 Therapeutics 4 Spinal Puncture 4 Carboplatin 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 fludarabine 3 entinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02768337 2024-01-31

CamBMT1

Cambridge University Hospitals NHS Foundation Trust

Phase 1/2 Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡